A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
Clinical trial NCT03165422 · COMPLETED
Trial details
- NCT number
- NCT03165422
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-12-29
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.